Organon (OGN) Stock Forecast & Price Target

Compare

1,089 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

OGN Analyst Ratings

Moderate Sell

0 Buy

1 Hold

3 Sell

Based on 4 analysts giving stock ratings to

Organon

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

OGN Stock 12 Month Forecast

Average Price Target

$9.38

▲(13.15% Upside)

Based on 4 Wall Street analysts offering 12 month price targets for Organon in the last 3 months. The average price target is $9.38 with a high forecast of $12.00 and a low forecast of $7.50. The average price target represents a 13.15% change from the last price of $8.29.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","16":"$16","7.75":"$7.75","10.5":"$10.5","13.25":"$13.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$12.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$9.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,7.75,10.5,13.25,16],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.2,8.492307692307692,8.784615384615384,9.076923076923077,9.369230769230768,9.661538461538461,9.953846153846154,10.246153846153845,10.538461538461538,10.830769230769231,11.123076923076923,11.415384615384616,11.707692307692309,{"y":12,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.2,8.29076923076923,8.381538461538462,8.472307692307693,8.563076923076922,8.653846153846153,8.744615384615384,8.835384615384616,8.926153846153847,9.016923076923078,9.107692307692307,9.198461538461538,9.28923076923077,{"y":9.38,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.2,8.146153846153846,8.092307692307692,8.038461538461538,7.984615384615384,7.93076923076923,7.8769230769230765,7.823076923076923,7.769230769230769,7.7153846153846155,7.661538461538461,7.607692307692307,7.553846153846154,{"y":7.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":15.17,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":14.804,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.029,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.382,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.205,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":10.001,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":9.703,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.394,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.96,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":6.731,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":7.6,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":7.17,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.2,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$12.00

Average Price Target$9.38

Lowest Price Target$7.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Glen Santangelo

Barclays

$7.5

Sell

-9.53%

Downside

Reiterated

01/21/26

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT) and Organon (NYSE: OGN)

Terence Flynn

Morgan Stanley

$10→$9

Hold

8.56%

Upside

Reiterated

11/11/25

Organon price target lowered to $9 from $10 at Morgan StanleyOrganon price target lowered to $9 from $10 at Morgan Stanley

Chris Schott

J.P. Morgan

$14→$12

Sell

44.75%

Upside

Reiterated

11/11/25

Organon price target lowered to $12 from $14 at JPMorganOrganon price target lowered to $12 from $14 at JPMorgan

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

Sell

8.56%

Upside

Reiterated

11/10/25

Bank of America Securities Sticks to Its Sell Rating for Organon (OGN)

David Amsellem

Piper Sandler

$18→$5

Sell

-39.69%

Downside

Downgraded

10/27/25

Organon downgraded to Underweight from Overweight at Piper SandlerOrganon downgraded to Underweight from Overweight at Piper Sandler

Navann Ty

Exane BNP Paribas

$29→$16

Buy

93.00%

Upside

Reiterated

05/22/25

Organon Co. (OGN) PT Lowered to $16 at BNP Paribas ExaneBNP Paribas Exane analyst Navaan Ty lowered the price target on Organon Co. (NYSE: OGN) to $16.00 (from $29.00) while maintaining a Outperform rating.

Umer Raffat

Evercore ISI

Hold

―

Downgraded

05/02/25

Evercore ISI downgrades Organon (OGN) to a Hold

Steve Scala

TD Cowen

$19→$15

Hold

80.94%

Upside

Reiterated

04/22/25

Organon Co. (OGN) PT Lowered to $15 at TD CowenTD Cowen analyst Steve Scala lowered the price target on Organon Co. (NYSE: OGN) to $15.00 (from $19.00) while maintaining a Hold rating.

Chris Shibutani

Goldman Sachs

$20→$19

Hold

129.19%

Upside

Reiterated

02/14/25

Organon Co. (OGN) PT Lowered to $19 at Goldman SachsGoldman Sachs analyst Chris Shibutani lowered the price target on Organon Co. (NYSE: OGN) to $19.00 (from $20.00) while maintaining a Neutral rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Glen Santangelo

Barclays

$7.5

Sell

-9.53%

Downside

Reiterated

01/21/26

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT) and Organon (NYSE: OGN)

Terence Flynn

Morgan Stanley

$10→$9

Hold

8.56%

Upside

Reiterated

11/11/25

Organon price target lowered to $9 from $10 at Morgan StanleyOrganon price target lowered to $9 from $10 at Morgan Stanley

Chris Schott

J.P. Morgan

$14→$12

Sell

44.75%

Upside

Reiterated

11/11/25

Organon price target lowered to $12 from $14 at JPMorganOrganon price target lowered to $12 from $14 at JPMorgan

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

Sell

8.56%

Upside

Reiterated

11/10/25

Bank of America Securities Sticks to Its Sell Rating for Organon (OGN)

David Amsellem

Piper Sandler

$18→$5

Sell

-39.69%

Downside

Downgraded

10/27/25

Organon downgraded to Underweight from Overweight at Piper SandlerOrganon downgraded to Underweight from Overweight at Piper Sandler

Navann Ty

Exane BNP Paribas

$29→$16

Buy

93.00%

Upside

Reiterated

05/22/25

Umer Raffat

Evercore ISI

Hold

―

Downgraded

05/02/25

Evercore ISI downgrades Organon (OGN) to a Hold

Steve Scala

TD Cowen

$19→$15

Hold

80.94%

Upside

Reiterated

04/22/25

Organon Co. (OGN) PT Lowered to $15 at TD CowenTD Cowen analyst Steve Scala lowered the price target on Organon Co. (NYSE: OGN) to $15.00 (from $19.00) while maintaining a Hold rating.

Chris Shibutani

Goldman Sachs

$20→$19

Hold

129.19%

Upside

Reiterated

02/14/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Organon

3 Months

xxx

Success Rate

3/5 ratings generated profit

Average Return

+10.28%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +10.28% per trade.

1 Year

Chris SchottJ.P. Morgan

Success Rate

4/5 ratings generated profit

Average Return

+23.10%

reiterated a sell rating 3 months ago

Copying Chris Schott's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +23.10% per trade.

2 Years

xxx

Success Rate

4/5 ratings generated profit

Average Return

+25.38%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +25.38% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OGN Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, OGN has received 0 Buy Ratings, 38 Hold Ratings, and 2 Sell Ratings. OGN average Analyst price target in the past 3 months is 9.38.

Each month's total comprises the sum of three months' worth of ratings.

OGN Financial Forecast

OGN Earnings Forecast

Next quarter’s earnings estimate for OGN is $0.73 with a range of $0.62 to $0.81. The previous quarter’s EPS was $1.01. OGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year OGN has Performed in-line its overall industry.

OGN Sales Forecast

Next quarter’s sales forecast for OGN is $1.54B with a range of $1.49B to $1.59B. The previous quarter’s sales results were $1.60B. OGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year OGN has Performed in-line its overall industry.

OGN Stock Forecast FAQ

What is OGN’s average 12-month price target, according to analysts?

Based on analyst ratings, Organon’s 12-month average price target is 9.38.

What is OGN’s upside potential, based on the analysts’ average price target?

Organon has 13.15% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is OGN a Buy, Sell or Hold?

Organon has a consensus rating of Moderate Sell which is based on 0 buy ratings, 1 hold ratings and 3 sell ratings.

What is Organon’s price target?

The average price target for Organon is 9.38. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $12.00 ,the lowest forecast is $7.50. The average price target represents 13.15% Increase from the current price of $8.29.

What do analysts say about Organon?

Organon’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 4 Wall Streets Analysts.

How can I buy shares of OGN?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Organon (OGN) Stock Forecast & Price Target

OGN Analyst Ratings

OGN Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Organon

OGN Analyst Recommendation Trends

OGN Financial Forecast

OGN Earnings Forecast

OGN Sales Forecast

OGN Stock Forecast FAQ

Detailed List of Analyst Forecasts